CHM chimeric therapeutics limited

Ann: ADVENT-AML Phase 1B clinical trial update, page-16

  1. 8,251 Posts.
    lightbulb Created with Sketch. 3238
    Would be nice but I dont know about that, lets be realistic here, this is based on 3 people, which the market generally views as insufficient to revalue a company meaningfully unless the results are extraordinary.

    The fact that 2/3 achieved CRi in a hard-to-treat population is above expectations, so we are seeing a small rally. I think this is pretty much what we will get here.

    Also the fact the company needs cash might be a bit stifling to upward momentum, with 100s of millions of shares in profit now. Dont think we are seeing 2 cents any time soon.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $15.69K 3.919M

Buyers (Bids)

No. Vol. Price($)
26 21936206 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 24685267 27
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.